{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:27:22Z","timestamp":1792052842773,"version":"4.4.0"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11064-024-04244-3","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T03:04:06Z","timestamp":1727665446000},"page":"3208-3225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Emerging Trends: Neurofilament Biomarkers in Precision Neurology"],"prefix":"10.1007","volume":"49","author":[{"given":"Priti","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhash Nath","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"issue":"43","key":"4244_CR1","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.2174\/1381612825666191210154535","volume":"25","author":"Y Lee","year":"2019","unstructured":"Lee Y, Lee BH, Yip W, Chou P, Yip BS (2019) Neurofilament proteins as prognostic biomarkers in neurological disorders. Curr Pharm Des 25(43):4560\u20134569","journal-title":"Curr Pharm Des"},{"issue":"8","key":"4244_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H (2019) Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry 90(8):870\u2013881","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4244_CR3","unstructured":"Braissant O (2006) Neurofilament proteins in brain diseases. In: New research on neurofilament proteins. pp 25\u201351. https:\/\/serval.unil.ch\/resource\/serval:BIB_930EC2B691CE.P001\/REF.pdf"},{"issue":"7","key":"4244_CR4","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/brain\/awaa098","volume":"143","author":"AR Gafson","year":"2020","unstructured":"Gafson AR, Barth\u00e9lemy NR, Bomont P, Carare RO, Durham HD, Julien JP et al (2020) Neurofilaments: neurobiological foundations for biomarker applications. Brain 143(7):1975\u20131998","journal-title":"Brain"},{"issue":"2","key":"4244_CR5","first-page":"056","volume":"7","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Arceneaux L, Culicchia F, Lukiw WJ (2021) Neurofilament light (NF-L) chain protein from a highly polymerized structural component of the neuronal cytoskeleton to a neurodegenerative disease biomarker in the periphery. HSOA J Alzheimers Neurodegener Dis 7(2):056","journal-title":"HSOA J Alzheimers Neurodegener Dis"},{"issue":"7","key":"4244_CR6","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/cells9071604","volume":"9","author":"M Potokar","year":"2020","unstructured":"Potokar M, Morita M, Wiche G, Jorga\u010devski J (2020) The diversity of intermediate filaments in astrocytes. Cells 9(7):1604","journal-title":"Cells"},{"issue":"7280","key":"4244_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature08908","volume":"463","author":"DA Fletcher","year":"2010","unstructured":"Fletcher DA, Mullins RD (2010) Cell mechanics and the cytoskeleton. Nature 463(7280):485\u2013492","journal-title":"Nature"},{"key":"4244_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ceb.2020.10.011","volume":"68","author":"P Bomont","year":"2021","unstructured":"Bomont P (2021) The dazzling rise of neurofilaments: physiological functions and roles as biomarkers. Curr Opin Cell Biol 68:181\u2013191","journal-title":"Curr Opin Cell Biol"},{"key":"4244_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2024.102326","volume":"87","author":"JV van Asperen","year":"2024","unstructured":"van Asperen JV, Kotaich F, Caillol D, Bomont P (2024) Neurofilaments: novel findings and future challenges. Curr Opin Cell Biol 87:102326","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"4244_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pneurobio.2011.07.009","volume":"95","author":"G Riboldi","year":"2011","unstructured":"Riboldi G, Nizzardo M, Simone C, Falcone M, Bresolin N, Comi GP, Corti S (2011) ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development. Prog Neurobiol 95(2):133\u2013148","journal-title":"Prog Neurobiol"},{"issue":"19","key":"4244_CR11","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.febslet.2015.07.024","volume":"589","author":"M Kornreich","year":"2015","unstructured":"Kornreich M, Avinery R, Malka-Gibor E, Laser-Azogui A, Beck R (2015) Order and disorder in intermediate filament proteins. FEBS Lett 589(19):2464\u20132476","journal-title":"FEBS Lett"},{"issue":"11","key":"4244_CR12","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3390\/cells9112365","volume":"9","author":"M Bergoug","year":"2020","unstructured":"Bergoug M, Doudeau M, Godin F, Mosrin C, Vall\u00e9e B, B\u00e9n\u00e9detti H (2020) Neurofibromin structure, functions and regulation. Cells 9(11):2365","journal-title":"Cells"},{"key":"4244_CR13","first-page":"47","volume":"14","author":"PN Tripathi","year":"2024","unstructured":"Tripathi PN, Lodhi A, Rai SN, Nandi NK, Dumoga S, Yadav P, Tiwari AK, Singh SK, El-Shorbagi AN, Chaudhary S. Review of pharmacotherapeutic targets in Alzheimer\u2019s disease and its management using traditional medicinal plants. Degener Neurol Neuromuscul Dis 14:47\u201374.","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"10","key":"4244_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T et al (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14(10):577\u2013589","journal-title":"Nat Rev Neurol"},{"key":"4244_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.658202","volume":"15","author":"D Pukoli","year":"2021","unstructured":"Pukoli D, Poly\u00e1k H, Rajda C, V\u00e9csei L (2021) Kynurenines and neurofilament light chain in multiple sclerosis. Front Neurosci 15:658202","journal-title":"Front Neurosci"},{"key":"4244_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ceb.2015.01.003","volume":"32","author":"A Laser-Azogui","year":"2015","unstructured":"Laser-Azogui A, Kornreich M, Malka-Gibor E, Beck R (2015) Neurofilament assembly and function during neuronal development. Curr Opin Cell Biol 32:92\u2013101","journal-title":"Curr Opin Cell Biol"},{"issue":"14","key":"4244_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2024151118","volume":"118","author":"H Rahmani","year":"2021","unstructured":"Rahmani H, Ma W, Hu Z, Daneshparvar N, Taylor DW, McCammon JA et al (2021) The myosin II coiled-coil domain atomic structure in its native environment. Proc Natl Acad Sci 118(14):e2024151118","journal-title":"Proc Natl Acad Sci"},{"key":"4244_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00441-014-2082-7","volume":"360","author":"BJ Gentil","year":"2015","unstructured":"Gentil BJ, Tibshirani M, Durham HD (2015) Neurofilament dynamics and involvement in neurological disorders. Cell Tissue Res 360:609\u2013620","journal-title":"Cell Tissue Res"},{"issue":"1","key":"4244_CR19","doi-asserted-by":"publisher","first-page":"19525","DOI":"10.1038\/s41598-020-76076-4","volume":"10","author":"S Pattabiraman","year":"2020","unstructured":"Pattabiraman S, Azad GK, Amen T, Brielle S, Park JE, Sze SK et al (2020) Vimentin protects differentiating stem cells from stress. Sci Rep 10(1):19525","journal-title":"Sci Rep"},{"issue":"3\u20134","key":"4244_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/cm.21597","volume":"77","author":"CJ Bott","year":"2020","unstructured":"Bott CJ, Winckler B (2020) Intermediate filaments in developing neurons: beyond structure. Cytoskeleton 77(3\u20134):110\u2013128","journal-title":"Cytoskeleton"},{"issue":"1","key":"4244_CR21","doi-asserted-by":"publisher","first-page":"46271","DOI":"10.1016\/B978-0-12-816346-7.00013-0","volume":"7","author":"F Rizzo","year":"2017","unstructured":"Rizzo F, Ramirez A, Compagnucci C, Salani S, Melzi V, Bordoni A et al (2017) Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease that is partially rescued by riboflavin. Sci Rep 7(1):46271. https:\/\/doi.org\/10.1016\/B978-0-12-816346-7.00013-0","journal-title":"Sci Rep"},{"key":"4244_CR22","doi-asserted-by":"publisher","unstructured":"Yokobori S, Nakae R, Yokota H (2020) Neurofilaments light chain\/neurofilaments heavy chain. In: Biomarkers for traumatic brain injury. Academic Press, pp 193\u2013203. https:\/\/doi.org\/10.1016\/B978-0-12-816346-7.00013-0","DOI":"10.1016\/B978-0-12-816346-7.00013-0"},{"issue":"4","key":"4244_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/01658107.2022.2025852","volume":"46","author":"R Weissert","year":"2022","unstructured":"Weissert R, Hugosson T, Petzold A (2022) Upregulated retinal neurofilament expression in experimental optic neuritis. Neuro-Ophthalmology 46(4):215\u2013219","journal-title":"Neuro-Ophthalmology"},{"key":"4244_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6787-9_26","volume-title":"Intermediate filament cytoskeleton","year":"2004","unstructured":"Omary MB, Coulombe PA (eds) (2004) Intermediate filament cytoskeleton, vol 78. Gulf Professional Publishing, Houston. https:\/\/doi.org\/10.1007\/978-1-4419-6787-9_26"},{"key":"4244_CR25","doi-asserted-by":"publisher","unstructured":"Rudrabhatla P, Pant HC (2011) Topographic regulation of neuronal intermediate filament proteins by phosphorylation: in health and disease. In: Cytoskeleton of the nervous system. pp 627\u2013656. https:\/\/doi.org\/10.1007\/978-1-4419-6787-9_26","DOI":"10.1007\/978-1-4419-6787-9_26"},{"key":"4244_CR26","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00249-010-0585-z","volume":"39","author":"FAM Leermakers","year":"2010","unstructured":"Leermakers FAM, Zhulina EB (2010) How the projection domains of NF-L and \u03b1-internexin determine the conformations of NF-M and NF-H in neurofilaments. Eur Biophys J 39:1323\u20131334","journal-title":"Eur Biophys J"},{"issue":"11","key":"4244_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41579-019-0243-0","volume":"17","author":"B Macek","year":"2019","unstructured":"Macek B, Forchhammer K, Hardouin J, Weber-Ban E, Grangeasse C, Mijakovic I (2019) Protein post-translational modifications in bacteria. Nat Rev Microbiol 17(11):651\u2013664","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"4244_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jmb.2010.11.022","volume":"405","author":"W Stevenson","year":"2011","unstructured":"Stevenson W, Chang R, Gebremichael Y (2011) Phosphorylation-mediated conformational changes in the mouse neurofilament architecture: insight from a neurofilament brush model. J Mol Biol 405(4):1101\u20131118","journal-title":"J Mol Biol"},{"issue":"2","key":"4244_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nbd.2012.01.013","volume":"46","author":"L Cantuti-Castelvetri","year":"2012","unstructured":"Cantuti-Castelvetri L, Zhu H, Givogri MI, Chidavaenzi RL, Lopez-Rosas A, Bongarzone ER (2012) Psychosine induces the dephosphorylation of neurofilaments by deregulation of PP1 and PP2A phosphatases. Neurobiol Dis 46(2):325\u2013335","journal-title":"Neurobiol Dis"},{"issue":"8","key":"4244_CR30","doi-asserted-by":"publisher","first-page":"2100033","DOI":"10.1002\/bies.202100033","volume":"43","author":"X Pan","year":"2021","unstructured":"Pan X, Zhou Y, Hotulainen P, Meunier FA, Wang T (2021) The axonal radial contractility: structural basis underlying a new form of neural plasticity. BioEssays 43(8):2100033","journal-title":"BioEssays"},{"issue":"3","key":"4244_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/dneu.22560","volume":"78","author":"A Luarte","year":"2018","unstructured":"Luarte A, Cornejo VH, Bertin F, Gallardo J, Couve A (2018) The axonal endoplasmic reticulum: one organelle\u2014many functions in development, maintenance, and plasticity. Dev Neurobiol 78(3):181\u2013208","journal-title":"Dev Neurobiol"},{"issue":"4","key":"4244_CR32","doi-asserted-by":"publisher","first-page":"a018309","DOI":"10.1101\/cshperspect.a018309","volume":"9","author":"A Yuan","year":"2017","unstructured":"Yuan A, Rao MV, Veeranna, Nixon RA (2017) Neurofilaments and neurofilament proteins in health and disease. Cold Spring Harb Perspect Biol 9(4):a018309. https:\/\/doi.org\/10.1101\/cshperspect.a018309","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4244_CR33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.expneurol.2018.05.009","volume":"306","author":"E Villal\u00f3n","year":"2018","unstructured":"Villal\u00f3n E, Barry DM, Byers N, Frizzi K, Jones MR, Landayan DS et al (2018) Internode length is reduced during myelination and remyelination by neurofilament medium phosphorylation in motor axons. Exp Neurol 306:158\u2013168","journal-title":"Exp Neurol"},{"key":"4244_CR34","doi-asserted-by":"publisher","first-page":"102037","DOI":"10.1016\/j.arr.2023.102037","volume":"90","author":"J Elmers","year":"2023","unstructured":"Elmers J, Colzato LS, Akg\u00fcn K, Ziemssen T, Beste C (2023) Neurofilaments\u2013small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span. Ageing Res Rev 90:102037","journal-title":"Ageing Res Rev"},{"key":"4244_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.conb.2020.02.001","volume":"61","author":"BA Gordon","year":"2020","unstructured":"Gordon BA (2020) Neurofilaments in disease: what do we know? Curr Opin Neurobiol 61:105\u2013115","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"4244_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-019-0318-4","volume":"14","author":"A Didonna","year":"2019","unstructured":"Didonna A, Opal P (2019) The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders. Mol Neurodegener 14(1):19","journal-title":"Mol Neurodegener"},{"issue":"4","key":"4244_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/ane.13698","volume":"146","author":"E Sturmey","year":"2022","unstructured":"Sturmey E, Malaspina A (2022) Blood biomarkers in ALS: challenges, applications and novel frontiers. Acta Neurol Scand 146(4):375\u2013388","journal-title":"Acta Neurol Scand"},{"key":"4244_CR38","doi-asserted-by":"publisher","first-page":"102290","DOI":"10.1016\/j.arr.2024.102290","volume":"96","author":"S Lista","year":"2024","unstructured":"Lista S, Mapstone M, Caraci F, Emanuele E, L\u00f3pez-Ortiz S, Mart\u00edn-Hern\u00e1ndez J et al (2024) A critical appraisal of blood-based biomarkers for Alzheimer\u2019s disease. Ageing Res Rev 96:102290","journal-title":"Ageing Res Rev"},{"key":"4244_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-0716-2376-3_10","volume-title":"Cancer cell biology: methods and protocols","author":"MS Tabatabaei","year":"2022","unstructured":"Tabatabaei MS, Ahmed M (2022) Enzyme-linked immunosorbent assay (ELISA). In: Cancer cell biology: methods and protocols. Springer US, New York, pp 115\u2013134. https:\/\/urn.fi\/URN:ISBN:978-952-12-3460-6"},{"key":"4244_CR40","unstructured":"Isoniemi K (2016) Phosphorylation as a mediator of protein function in cell migration, differentiation, and death: vimentin, AATF, and Par-4 in the spotlight. https:\/\/urn.fi\/URN:ISBN:978-952-12-3460-6"},{"key":"4244_CR41","doi-asserted-by":"publisher","first-page":"125529","DOI":"10.1016\/j.talanta.2023.125529","volume":"270","author":"R Dong","year":"2023","unstructured":"Dong R, Yi N, Jiang D (2023) Advances in single molecule arrays (SIMOA) for ultra-sensitive detection of biomolecules. Talanta 270:125529","journal-title":"Talanta"},{"issue":"5","key":"4244_CR42","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1039\/D2LC00783E","volume":"23","author":"DC Duffy","year":"2023","unstructured":"Duffy DC (2023) Digital detection of proteins. Lab Chip 23(5):818\u2013847","journal-title":"Lab Chip"},{"key":"4244_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","volume":"57","author":"Z Alirezaei","year":"2020","unstructured":"Alirezaei Z, Pourhanifeh MH, Borran S, Nejati M, Mirzaei H, Hamblin MR (2020) Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders. Mol Neurobiol 57:469\u2013491","journal-title":"Mol Neurobiol"},{"issue":"2","key":"4244_CR44","doi-asserted-by":"publisher","first-page":"fcad067","DOI":"10.1093\/braincomms\/fcad067","volume":"5","author":"G Shaw","year":"2023","unstructured":"Shaw G, Madorsky I, Li Y, Wang Y, Jorgensen M, Rana S, Fuller DD (2023) Uman-type neurofilament light antibodies are effective reagents for the imaging of neurodegeneration. Brain Commun 5(2):fcad067","journal-title":"Brain Commun"},{"key":"4244_CR45","first-page":"57","volume":"1","author":"L Garc\u00eda-Descalzo","year":"2012","unstructured":"Garc\u00eda-Descalzo L, Garc\u00eda-L\u00f3pez E, Alc\u00e1zar A, Baquero F, Cid C (2012) Gel electrophoresis of proteins. Gel Electrophoresis\/Book 1:57\u201368","journal-title":"Gel Electrophoresis\/Book"},{"issue":"1","key":"4244_CR46","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41467-022-27956-y","volume":"13","author":"A Arsi\u0107","year":"2022","unstructured":"Arsi\u0107 A, Hagemann C, Stajkovi\u0107 N, Schubert T, Niki\u0107-Spiegel I (2022) Minimal genetically encoded tags for fluorescent protein labeling in living neurons. Nat Commun 13(1):314","journal-title":"Nat Commun"},{"key":"4244_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116327","volume":"142","author":"A Sharma","year":"2021","unstructured":"Sharma A, Tok AIY, Alagappan P, Liedberg B (2021) Point of care testing of sports biomarkers: potential applications, recent advances and future outlook. Trends Anal Chem 142:116327","journal-title":"Trends Anal Chem"},{"key":"4244_CR48","doi-asserted-by":"publisher","first-page":"104587","DOI":"10.1016\/j.jddst.2023.104587","volume":"85","author":"MS Razavi","year":"2023","unstructured":"Razavi MS, Abdollahi A, Malek-Khatabi A, Ejarestaghi NM, Atashi A, Yousefi N et al (2023) Recent advances in PLGA-based nanofibers as anticancer drug delivery systems. J Drug Deliv Sci Technol 85:104587","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"4244_CR49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00580-021-03302-4","volume":"31","author":"H Ahsan","year":"2022","unstructured":"Ahsan H (2022) Monoplex and multiplex immunoassays: approval, advancements, and alternatives. Comp Clin Pathol 31(2):333\u2013345","journal-title":"Comp Clin Pathol"},{"issue":"2","key":"4244_CR50","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1021\/acsabm.0c01319","volume":"4","author":"H Moorthy","year":"2021","unstructured":"Moorthy H, Govindaraju T (2021) Dendrimer architectonics to treat cancer and neurodegenerative diseases with implications in theranostics and personalized medicine. ACS Appl Bio Mater 4(2):1115\u20131139","journal-title":"ACS Appl Bio Mater"},{"key":"4244_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2019.125924","volume":"311","author":"D Chen","year":"2020","unstructured":"Chen D, Delmas JM, Hurtaud-Pessel D, Verdon E (2020) Development of a multi-class method to determine nitroimidazoles, nitrofurans, pharmacologically active dyes and chloramphenicol in aquaculture products by liquid chromatography-tandem mass spectrometry. Food Chem 311:125924","journal-title":"Food Chem"},{"issue":"2","key":"4244_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-981-10-6766-2_5","volume":"159","author":"M Korecka","year":"2021","unstructured":"Korecka M, Shaw LM (2021) Mass spectrometry-based methods for robust measurement of Alzheimer\u2019s disease biomarkers in biological fluids. J Neurochem 159(2):211\u2013233. https:\/\/doi.org\/10.1007\/978-981-10-6766-2_5","journal-title":"J Neurochem"},{"key":"4244_CR53","doi-asserted-by":"publisher","unstructured":"Hosseini S, V\u00e1zquez-Villegas P, Rito-Palomares M, Martinez-Chapa SO, Hosseini S, V\u00e1zquez-Villegas P et al (2018) Advantages, disadvantages and modifications of conventional ELISA. In: Enzyme-linked immunosorbent assay (ELISA) from A to Z. pp 67\u2013115. https:\/\/doi.org\/10.1007\/978-981-10-6766-2_5","DOI":"10.1007\/978-981-10-6766-2_5"},{"key":"4244_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803475","volume":"12","author":"L Ngarka","year":"2022","unstructured":"Ngarka L, Siewe Fodjo JN, Aly E, Masocha W, Njamnshi AK (2022) The interplay between neuroinfections, the immune system and neurological disorders: a focus on Africa. Front Immunol 12:803475","journal-title":"Front Immunol"},{"issue":"1","key":"4244_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/s24010037","volume":"24","author":"S Das","year":"2023","unstructured":"Das S, Dey MK, Devireddy R, Gartia MR (2023) Biomarkers in cancer detection, diagnosis, and prognosis. Sensors 24(1):37","journal-title":"Sensors"},{"issue":"10","key":"4244_CR56","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.neurol.2016.07.015","volume":"172","author":"A Parlakian","year":"2016","unstructured":"Parlakian A, Paulin D, Izmiryan A, Xue Z, Li Z (2016) Intermediate filaments in peripheral nervous system: their expression, dysfunction and diseases. Revue Neurologique 172(10):607\u2013613","journal-title":"Revue Neurologique"},{"issue":"3","key":"4244_CR57","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/brainsci14030272","volume":"14","author":"C Gallingani","year":"2024","unstructured":"Gallingani C, Carbone C, Tondelli M, Zamboni G (2024) Neurofilaments light chain in neurodegenerative dementias: a review of imaging correlates. Brain Sci 14(3):272","journal-title":"Brain Sci"},{"issue":"21","key":"4244_CR58","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.3390\/ijms232112924","volume":"23","author":"U Sehar","year":"2022","unstructured":"Sehar U, Rawat P, Reddy AP, Kopel J, Reddy PH (2022) Amyloid beta in aging and Alzheimer\u2019s disease. Int J Mol Sci 23(21):12924","journal-title":"Int J Mol Sci"},{"key":"4244_CR59","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s11064-023-04081-w","volume":"49","author":"N Siddiqui","year":"2024","unstructured":"Siddiqui N, Saifi A, Chaudhary A et al (2024) Multifaceted neuroprotective role of punicalagin: a review. Neurochem Res 49: 1427\u20131436. https:\/\/doi.org\/10.1007\/s11064-023-04081-w","journal-title":"Neurochem Res"},{"key":"4244_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-017-0297-z","volume":"9","author":"M Crous-Bou","year":"2017","unstructured":"Crous-Bou M, Minguill\u00f3n C, Gramunt N, Molinuevo JL (2017) Alzheimer\u2019s disease prevention: from risk factors to early intervention. Alzheimers Res Ther 9:1\u20139","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"4244_CR61","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3233\/JAD-200175","volume":"75","author":"A Kaipainen","year":"2020","unstructured":"Kaipainen A, J\u00e4\u00e4skel\u00e4inen O, Liu Y, Haapalinna F, Nyk\u00e4nen N, Vanninen R et al (2020) Cerebrospinal fluid and MRI biomarkers in neurodegenerative diseases: a retrospective memory clinic-based study. J Alzheimers Dis 75(3):751\u2013765","journal-title":"J Alzheimers Dis"},{"key":"4244_CR62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pneurobio.2018.12.006","volume":"174","author":"P Sharma","year":"2019","unstructured":"Sharma P, Srivastava P, Seth A, Tripathi PN, Banerjee AG, Shrivastava SK (2019) Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies. Prog Neurobio 174:53\u201389. https:\/\/doi.org\/10.1016\/j.pneurobio.2018.12.006","journal-title":"Prog Neurobio"},{"key":"4244_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL (2015) Amyloid \u03b2 oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol 129:183\u2013206","journal-title":"Acta Neuropathol"},{"key":"4244_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mcn.2018.12.004","volume":"97","author":"AD Cohen","year":"2019","unstructured":"Cohen AD, Landau SM, Snitz BE, Klunk WE, Blennow K, Zetterberg H (2019) Fluid and PET biomarkers for amyloid pathology in Alzheimer\u2019s disease. Mol Cell Neurosci 97:3\u201317","journal-title":"Mol Cell Neurosci"},{"key":"4244_CR65","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1590\/1980-57642016dn11-040005","volume":"11","author":"N Darling Custodio","year":"2017","unstructured":"Darling Custodio N, Montesinos R, Lira D, Herrera-P\u00e9rez E, Bardales Y, Valeriano-Lorenzo L (2017) Mixed dementia: a review of the evidence. Dement Neuropsychol 11:364\u2013370","journal-title":"Dement Neuropsychol"},{"issue":"5","key":"4244_CR66","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41582-020-0348-0","volume":"16","author":"NJ Ashton","year":"2020","unstructured":"Ashton NJ, Hye A, Rajkumar AP, Leuzy A, Snowden S, Su\u00e1rez-Calvet M et al (2020) An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders. Nat Rev Neurol 16(5):265\u2013284","journal-title":"Nat Rev Neurol"},{"key":"4244_CR67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cortex.2023.12.009","volume":"172","author":"G Giacomucci","year":"2024","unstructured":"Giacomucci G, Moschini V, Piazzesi D, Padiglioni S, Caruso C, Nuti C et al (2024) Disentangling empathy impairment along Alzheimer\u2019s disease continuum: from subjective cognitive decline to Alzheimer\u2019s dementia. Cortex 172:125\u2013140","journal-title":"Cortex"},{"key":"4244_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2022.116605","volume":"152","author":"P Peng","year":"2022","unstructured":"Peng P, Liu C, Li Z, Xue Z, Mao P, Hu J et al (2022) Emerging ELISA derived technologies for in vitro diagnostics. Trends Anal Chem 152:116605","journal-title":"Trends Anal Chem"},{"issue":"5","key":"4244_CR69","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K, Alzheimer\u2019s Disease Neuroimaging Initiative (2017) Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol 74(5):557\u2013566","journal-title":"JAMA Neurol"},{"issue":"1","key":"4244_CR70","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.arr.2012.07.003","volume":"12","author":"J Reijnders","year":"2013","unstructured":"Reijnders J, van Heugten C, van Boxtel M (2013) Cognitive interventions in healthy older adults and people with mild cognitive impairment: a systematic review. Ageing Res Rev 12(1):263\u2013275","journal-title":"Ageing Res Rev"},{"issue":"7","key":"4244_CR71","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K (2019) Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol 76(7):791\u2013799","journal-title":"JAMA Neurol"},{"issue":"2","key":"4244_CR72","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","volume":"25","author":"O Preische","year":"2019","unstructured":"Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C et al (2019) Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease. Nat Med 25(2):277\u2013283","journal-title":"Nat Med"},{"key":"4244_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0404-9","volume":"10","author":"P Lewczuk","year":"2018","unstructured":"Lewczuk P, Ermann N, Andreasson U, Schultheis C, Podhorna J, Spitzer P et al (2018) Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease. Alzheimers Res Ther 10:1\u201310","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"4244_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16089","volume":"31","author":"S Mazzeo","year":"2024","unstructured":"Mazzeo S, Ingannato A, Giacomucci G, Manganelli A, Moschini V, Balestrini J, Cavaliere A, Morinelli C, Galdo G, Emiliani F, Piazzesi D, Crucitti C, Frigerio D, Polito C, Berti V, Bagnoli S, Padiglioni S, Sorbi S, Nacmias B, Bessi V (2024) Plasma neurofilament light chain predicts Alzheimer\u2019s disease in patients with subjective cognitive decline and mild cognitive impairment: a cross-sectional and longitudinal study. Eur J Neurol 31(1):e16089. https:\/\/doi.org\/10.1111\/ene.16089","journal-title":"Eur J Neurol"},{"key":"4244_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/9781118486160.ch8","volume":"14","author":"G Cipriani","year":"2020","unstructured":"Cipriani G, Danti S, Picchi L, Nuti A, Fiorino MD (2020) Daily functioning and dementia. Dement Neuropsychol 14:93\u2013102. https:\/\/doi.org\/10.1002\/9781118486160.ch8","journal-title":"Dement Neuropsychol"},{"issue":"2","key":"4244_CR76","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/JAD-160527","volume":"54","author":"M Vijayan","year":"2016","unstructured":"Vijayan M, Reddy PH (2016) Stroke, vascular dementia, and Alzheimer\u2019s disease: molecular links. J Alzheimers Dis 54(2):427\u2013443","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"4244_CR77","doi-asserted-by":"publisher","first-page":"e100054","DOI":"10.1136\/gpsych-2019-100054","volume":"32","author":"JMA Maclin","year":"2019","unstructured":"Maclin JMA, Wang T, Xiao S (2019) Biomarkers for the diagnosis of Alzheimer\u2019s disease, dementia Lewy body, frontotemporal dementia and vascular dementia. Gen Psychiatry 32(1):e100054","journal-title":"Gen Psychiatry"},{"key":"4244_CR78","doi-asserted-by":"publisher","unstructured":"Rossor M, Collinge J, Fox N, Mead S, Mummery C, Rohrer J et al (2016) Dementia and cognitive impairment. In: Neurology: a Queen Square Textbook. pp 289\u2013336. https:\/\/doi.org\/10.1016\/j.hsr.2024.100172","DOI":"10.1016\/j.hsr.2024.100172"},{"key":"4244_CR79","doi-asserted-by":"publisher","first-page":"100172","DOI":"10.1016\/j.hsr.2024.100172","volume":"11","author":"N Siddiqui","year":"2024","unstructured":"Siddiqui N, Talib M, Tripathi PN, Kumar A, Sharma A (2024) Therapeutic potential of baicalein against neurodegenerative diseases: an updated review. Heal Sci Rev 11:100172. https:\/\/doi.org\/10.1016\/j.hsr.2024.100172","journal-title":"Heal Sci Rev"},{"issue":"3","key":"4244_CR80","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/S1041610217002344","volume":"30","author":"SM Dyer","year":"2018","unstructured":"Dyer SM, Harrison SL, Laver K, Whitehead C, Crotty M (2018) An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr 30(3):295\u2013309","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"4244_CR81","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen MG, Kim MO, Geschwind MD (2018) Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol 10(4):a033118","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"26","key":"4244_CR82","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1056\/NEJMoa1803377","volume":"380","author":"JT Neumann","year":"2019","unstructured":"Neumann JT, Twerenbold R, Ojeda F, S\u00f6rensen NA, Chapman AR, Shah AS et al (2019) Application of high-sensitivity troponin in suspected myocardial infarction. N Engl J Med 380(26):2529\u20132540","journal-title":"N Engl J Med"},{"key":"4244_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-019-1591-0","volume":"20","author":"C Wattmo","year":"2020","unstructured":"Wattmo C, Blennow K, Hansson O (2020) Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer\u2019s disease. BMC Neurol 20:1\u201312","journal-title":"BMC Neurol"},{"issue":"18","key":"4244_CR84","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1523\/JNEUROSCI.0647-12.2012","volume":"32","author":"DM Barry","year":"2012","unstructured":"Barry DM, Stevenson W, Bober BG, Wiese PJ, Dale JM, Barry GS et al (2012) Expansion of neurofilament medium C terminus increases axonal diameter independent of increases in conduction velocity or myelin thickness. J Neurosci 32(18):6209\u20136219","journal-title":"J Neurosci"},{"issue":"10","key":"4244_CR85","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s40520-023-02521-9","volume":"35","author":"A Ladang","year":"2023","unstructured":"Ladang A, Kovacs S, Lengel\u00e9 L, Locquet M, Beaudart C, Reginster JY et al (2023) Neurofilament-light chains (NF-L), a biomarker of neuronal damage, is increased in patients with severe sarcopenia: results of the SarcoPhAge study. Aging Clin Exp Res 35(10):2029\u20132037","journal-title":"Aging Clin Exp Res"},{"key":"4244_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.679199","volume":"15","author":"F Verde","year":"2021","unstructured":"Verde F, Otto M, Silani V (2021) Neurofilament light chain as biomarker for amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci 15:679199","journal-title":"Front Neurosci"},{"issue":"1","key":"4244_CR87","doi-asserted-by":"publisher","first-page":"13394","DOI":"10.1038\/s41598-021-91038-0","volume":"11","author":"L He","year":"2021","unstructured":"He L, Morley JE, Aggarwal G, Nguyen AD, Vellas B, de Souto Barreto P et al (2021) Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults. Sci Rep 11(1):13394","journal-title":"Sci Rep"},{"issue":"10","key":"4244_CR88","doi-asserted-by":"publisher","first-page":"e1069","DOI":"10.1212\/WNL.0000000000207581","volume":"101","author":"LA Giannini","year":"2023","unstructured":"Giannini LA, Seelaar H, van der Ende EL, Poos JM, Jiskoot LC, Dopper EG et al (2023) Clinical value of longitudinal serum neurofilament light chain in prodromal genetic frontotemporal dementia. Neurology 101(10):e1069\u2013e1082","journal-title":"Neurology"},{"issue":"12","key":"4244_CR89","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S1474-4422(19)30354-0","volume":"18","author":"EL van der Ende","year":"2019","unstructured":"van der Ende EL, Meeter LH, Poos JM, Panman JL, Jiskoot LC, Dopper EG et al (2019) Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study. Lancet Neurol 18(12):1103\u20131111","journal-title":"Lancet Neurol"},{"issue":"2","key":"4244_CR90","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/14737175.2023.2177535","volume":"23","author":"A Lenka","year":"2023","unstructured":"Lenka A, Jankovic J (2023) How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson\u2019s disease? Expert Rev Neurother 23(2):107\u2013122","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"4244_CR91","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/nan.12535","volume":"45","author":"R Convery","year":"2019","unstructured":"Convery R, Mead S, Rohrer JD (2019) Clinical, genetic and neuroimaging features of frontotemporal dementia. Neuropathol Appl Neurobiol 45(1):6\u201318","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"4244_CR92","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1017\/cjn.2022.34","volume":"50","author":"SL Forrest","year":"2023","unstructured":"Forrest SL, Kovacs GG (2023) Current concepts of mixed pathologies in neurodegenerative diseases. Can J Neurol Sci 50(3):329\u2013345","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"4244_CR93","first-page":"1","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J et al (2017) Parkinson disease. Nat Rev Dis Prim 3(1):1\u201321","journal-title":"Nat Rev Dis Prim"},{"issue":"9","key":"4244_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274565","volume":"17","author":"L Ning","year":"2022","unstructured":"Ning L, Wang B (2022) Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: a systematic review and meta-analysis. PLoS ONE 17(9):e0274565","journal-title":"PLoS ONE"},{"issue":"3","key":"4244_CR95","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/acn3.290","volume":"3","author":"JC Rojas","year":"2016","unstructured":"Rojas JC, Karydas A, Bang J, Tsai RM, Blennow K, Liman V, Kramer JH, Rosen H, Miller BL, Zetterberg H, Boxer AL (2016) Plasma neurofilament light chain predicts progression in progressive supranuclear palsy. Ann Clin Transl Neurol 3(3):216\u2013225. https:\/\/doi.org\/10.1002\/acn3.290","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"4244_CR96","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/mds.28206","volume":"35","author":"B Mollenhauer","year":"2020","unstructured":"Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H et al (2020) Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression. Mov Disord 35(11):1999\u20132008","journal-title":"Mov Disord"},{"issue":"22","key":"4244_CR97","doi-asserted-by":"publisher","first-page":"e2185","DOI":"10.1212\/WNL.0000000000200338","volume":"98","author":"S Halloway","year":"2022","unstructured":"Halloway S, Desai P, Beck T, Aggarwal N, Agarwal P, Evans D et al (2022) Association of neurofilament light with the development and severity of Parkinson disease. Neurology 98(22):e2185\u2013e2193","journal-title":"Neurology"},{"issue":"3","key":"4244_CR98","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","volume":"76","author":"B Olsson","year":"2019","unstructured":"Olsson B, Portelius E, Cullen NC, Sandelius \u00c5, Zetterberg H, Andreasson U et al (2019) Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders. JAMA Neurol 76(3):318\u2013325","journal-title":"JAMA Neurol"},{"issue":"22","key":"4244_CR99","doi-asserted-by":"publisher","first-page":"16119","DOI":"10.3390\/ijms242216119","volume":"24","author":"C Toader","year":"2023","unstructured":"Toader C, Dobrin N, Brehar FM, Popa C, Covache-Busuioc RA, Glavan LA et al (2023) From recognition to remedy: the significance of biomarkers in neurodegenerative disease pathology. Int J Mol Sci 24(22):16119","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4244_CR100","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(22)00040-0","volume":"21","author":"BA Cree","year":"2022","unstructured":"Cree BA, Oksenberg JR, Hauser SL (2022) Multiple sclerosis: two decades of progress. Lancet Neurol 21(3):211\u2013214","journal-title":"Lancet Neurol"},{"issue":"2","key":"4244_CR101","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/cimb45020094","volume":"45","author":"G Papiri","year":"2023","unstructured":"Papiri G, D\u2019Andreamatteo G, Cacchi\u00f2 G, Alia S, Silvestrini M, Paci C et al (2023) Multiple sclerosis: inflammatory and neuroglial aspects. Curr Issues Mol Biol 45(2):1443\u20131470","journal-title":"Curr Issues Mol Biol"},{"issue":"3","key":"4244_CR102","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ana.23863","volume":"73","author":"FD Lublin","year":"2013","unstructured":"Lublin FD, Cofield SS, Cutter GR, Conwit R, Narayana PA, Nelson F et al (2013) Randomized study combining interferon and glatiramer acetate in multiple sclerosis. Ann Neurol 73(3):327\u2013340","journal-title":"Ann Neurol"},{"issue":"1","key":"4244_CR103","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis\u2014a review. Eur J Neurol 26(1):27\u201340","journal-title":"Eur J Neurol"},{"issue":"14","key":"4244_CR104","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.3390\/ijms22147377","volume":"22","author":"MK Sen","year":"2021","unstructured":"Sen MK, Almuslehi MS, Shortland PJ, Mahns DA, Coorssen JR (2021) Proteomics of multiple sclerosis: Inherent issues in defining the pathoetiology and identifying (early) biomarkers. Int J Mol Sci 22(14):7377","journal-title":"Int J Mol Sci"},{"key":"4244_CR105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/B978-0-444-52001-2.00002-9","volume":"122","author":"A Kutzelnigg","year":"2014","unstructured":"Kutzelnigg A, Lassmann H (2014) Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handb Clin Neurol 122:15\u201358","journal-title":"Handb Clin Neurol"},{"key":"4244_CR106","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s004150170248","volume":"248","author":"P Kapeller","year":"2001","unstructured":"Kapeller P, McLean MA, Griffin CM, Chard D, Parker GJ, Barker GJ et al (2001) Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol 248:131\u2013138","journal-title":"J Neurol"},{"issue":"10","key":"4244_CR107","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1177\/1352458520931785","volume":"26","author":"J Sastre-Garriga","year":"2020","unstructured":"Sastre-Garriga J, Tintor\u00e9 M, Montalban X (2020) Keeping standards of multiple sclerosis care through the COVID-19 pandemic. Mult Scler J 26(10):1153\u20131156","journal-title":"Mult Scler J"},{"issue":"5","key":"4244_CR108","doi-asserted-by":"publisher","first-page":"551","DOI":"10.26502\/fccm.92920221","volume":"5","author":"M Hay","year":"2021","unstructured":"Hay M, Ryan L, Huentelman M, Konhilas J, Hoyer-Kimura C, Beach TG et al (2021) Serum neurofilament light is elevated in COVID-19 positive adults in the ICU and is associated with co-morbid cardiovascular disease, neurological complications, and acuity of illness. Cardiol Cardiovasc Med 5(5):551","journal-title":"Cardiol Cardiovasc Med"},{"issue":"11","key":"4244_CR109","doi-asserted-by":"publisher","first-page":"e2016278","DOI":"10.1001\/jamanetworkopen.2020.16278","volume":"3","author":"T Plavina","year":"2020","unstructured":"Plavina T, Singh CM, Sangurdekar D, de Moor C, Engle B, Gafson A et al (2020) Association of serum neurofilament light levels with long-term brain atrophy in patients with a first multiple sclerosis episode. JAMA Netw Open 3(11):e2016278","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4244_CR110","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12038-020-00029-2","volume":"45","author":"SP Mutalik","year":"2020","unstructured":"Mutalik SP, Ghose A (2020) Axonal cytomechanics in neuronal development. J Biosci 45(1):64","journal-title":"J Biosci"},{"key":"4244_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.642384","volume":"15","author":"C Ferreira-Atuesta","year":"2021","unstructured":"Ferreira-Atuesta C, Reyes S, Giovanonni G, Gnanapavan S (2021) The evolution of neurofilament light chain in multiple sclerosis. Front Neurosci 15:642384","journal-title":"Front Neurosci"},{"key":"4244_CR112","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1007\/s00415-020-09917-x","volume":"268","author":"T Williams","year":"2021","unstructured":"Williams T, Zetterberg H, Chataway J (2021) Neurofilaments in progressive multiple sclerosis: a systematic review. J Neurol 268:3212\u20133222","journal-title":"J Neurol"},{"issue":"11","key":"4244_CR113","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/WNL.0000000000003085","volume":"87","author":"G Arrambide","year":"2016","unstructured":"Arrambide G, Espejo C, Eixarch H, Villar LM, Alvarez-Cerme\u00f1o JC, Pic\u00f3n C et al (2016) Neurofilament light chain level is a weak risk factor for the development of MS. Neurology 87(11):1076\u20131084","journal-title":"Neurology"},{"issue":"1","key":"4244_CR114","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaneurol.2019.3238","volume":"77","author":"K Bjornevik","year":"2020","unstructured":"Bjornevik K, Munger KL, Cortese M, Barro C, Healy BC, Niebuhr DW et al (2020) Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis. JAMA Neurol 77(1):58\u201364","journal-title":"JAMA Neurol"},{"key":"4244_CR115","doi-asserted-by":"publisher","first-page":"102807","DOI":"10.1016\/j.ebiom.2020.102807","volume":"56","author":"S Bittner","year":"2020","unstructured":"Bittner S, Steffen F, Uphaus T, Muthuraman M, Fleischer V, Salmen A et al (2020) Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study. EBioMedicine 56:102807","journal-title":"EBioMedicine"},{"issue":"8","key":"4244_CR116","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/brain\/awy154","volume":"141","author":"C Barro","year":"2018","unstructured":"Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y et al (2018) Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Brain 141(8):2382\u20132391","journal-title":"Brain"},{"key":"4244_CR117","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/B978-0-444-63521-1.00037-6","volume":"128","author":"I Cristofori","year":"2015","unstructured":"Cristofori I, Levin HS (2015) Traumatic brain injury and cognition. Handb Clin Neurol 128:579\u2013611","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"4244_CR118","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13049-022-01050-0","volume":"30","author":"S Rahim","year":"2022","unstructured":"Rahim S, Laugsand EA, Fyllingen EH, Rao V, Pantelatos RI, M\u00fcller TB et al (2022) Moderate and severe traumatic brain injury in general hospitals: a ten-year population-based retrospective cohort study in central Norway. Scand J Trauma Resusc Emerg Med 30(1):68","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"4244_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.105885","volume":"195","author":"A Seifi","year":"2020","unstructured":"Seifi A, Lacci JV, Godoy DA (2020) Incidence of brain death in the United States. Clin Neurol Neurosurg 195:105885","journal-title":"Clin Neurol Neurosurg"},{"issue":"38","key":"4244_CR120","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022363","volume":"99","author":"W Gao","year":"2020","unstructured":"Gao W, Zhang Z, Lv X, Wu Q, Yan J, Mao G, Xing W (2020) Neurofilament light chain level in traumatic brain injury: a system review and meta-analysis. Medicine 99(38):e22363","journal-title":"Medicine"},{"issue":"12","key":"4244_CR121","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/acn3.51234","volume":"7","author":"C Barro","year":"2020","unstructured":"Barro C, Chitnis T, Weiner HL (2020) Blood neurofilament light: a critical review of its application to neurologic disease. Ann Clin Transl Neurol 7(12):2508\u20132523","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"4244_CR122","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","volume":"91","author":"M Bacioglu","year":"2016","unstructured":"Bacioglu M, Maia LF, Preische O, Schelle J, Apel A, Kaeser SA et al (2016) Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases. Neuron 91(1):56\u201366","journal-title":"Neuron"},{"key":"4244_CR123","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.trsl.2022.11.008","volume":"255","author":"WT O\u2019Brien","year":"2023","unstructured":"O\u2019Brien WT, Wright DK, van Emmerik AL, Bain J, Brkljaca R, Christensen J et al (2023) Serum neurofilament light as a biomarker of vulnerability to a second mild traumatic brain injury. Transl Res 255:77\u201384","journal-title":"Transl Res"},{"key":"4244_CR124","unstructured":"Gill J (2020) Evaluation of serum neurofilament light chain as a diagnostic and prognostic biomarker in traumatic brain injury (Doctoral dissertation, University of British Columbia)"},{"issue":"1","key":"4244_CR125","first-page":"1","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Prim 3(1):1\u201319","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"4244_CR126","doi-asserted-by":"publisher","first-page":"39297","DOI":"10.1038\/srep39297","volume":"6","author":"N Riva","year":"2016","unstructured":"Riva N, Clarelli F, Domi T, Cerri F, Gallia F, Trimarco A et al (2016) Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis. Sci Rep 6(1):39297","journal-title":"Sci Rep"},{"issue":"10","key":"4244_CR127","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27(10):1918\u20131929","journal-title":"Eur J Neurol"},{"issue":"4","key":"4244_CR128","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1164\/rccm.201111-2042ST","volume":"185","author":"MB Parshall","year":"2012","unstructured":"Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J et al (2012) An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 185(4):435\u2013452","journal-title":"Am J Respir Crit Care Med"},{"key":"4244_CR129","volume":"28","author":"A Arshad","year":"2022","unstructured":"Arshad A, Atkinson AJ (2022) A 21st century view of the anatomy of the cardiac conduction system. Transl Res Anat 28:100204","journal-title":"Transl Res Anat"},{"issue":"1","key":"4244_CR130","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","volume":"12","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Janelidze S, Al Khleifat A, Leuzy A, van der Ende EL, Karikari TK, Benedet AL, Pascoal TA, Lle\u00f3 A, Parnetti L, Galimberti D, Bonanni L, Pilotto A, Padovani A, Lycke J, Novakova L, Axelsson M, Velayudhan L, Rabinovici GD, Miller B et al (2021) A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun 12(1):3400. https:\/\/doi.org\/10.1038\/s41467-021-23620-z","journal-title":"Nat Commun"},{"key":"4244_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01167","volume":"9","author":"K Poesen","year":"2019","unstructured":"Poesen K, Van Damme P (2019) Diagnostic and prognostic performance of neurofilaments in ALS. Front Neurol 9:433959","journal-title":"Front Neurol"},{"key":"4244_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-00406-3","volume":"15","author":"E Zucchi","year":"2020","unstructured":"Zucchi E, Bonetto V, Sorar\u00f9 G, Martinelli I, Parchi P, Liguori R, Mandrioli J (2020) Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol Neurodegener 15:1\u201320","journal-title":"Mol Neurodegener"},{"key":"4244_CR133","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00415-017-8730-6","volume":"265","author":"D Rossi","year":"2018","unstructured":"Rossi D, Volanti P, Brambilla L, Colletti T, Spataro R, La Bella V (2018) CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis. J Neurol 265:510\u2013521","journal-title":"J Neurol"},{"issue":"2","key":"4244_CR134","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","volume":"90","author":"F Verde","year":"2019","unstructured":"Verde F, Steinacker P, Weishaupt JH, Kassubek J, Oeckl P, Halbgebauer S et al (2019) Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 90(2):157\u2013164","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"4244_CR135","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12013-023-01143-2","volume":"81","author":"A Chauhan","year":"2023","unstructured":"Chauhan A, Singh J, Sangwan N, Dhawan R, Avti PK (2023) An atomic level investigation of sodium ions regulating agonist and antagonist binding in the active site of a novel target 5HT2BR against drug-resistant epilepsy. Cell Biochem Biophys 81(2):253\u2013267","journal-title":"Cell Biochem Biophys"},{"issue":"4","key":"4244_CR136","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3988\/jcn.2020.16.4.547","volume":"16","author":"H Kim","year":"2020","unstructured":"Kim H, Kim DW, Lee ST, Byun JI, Seo JG, No YJ et al (2020) Antiepileptic drug selection according to seizure type in adult patients with epilepsy. J Clin Neurol (Seoul, Korea) 16(4):547.","journal-title":"J Clin Neurol (Seoul, Korea)"},{"key":"4244_CR137","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s00044-022-02935-6","volume":"31","author":"SK Shrivastava","year":"2022","unstructured":"Shrivastava SK, Sinha O, Kumar M et al (2022) Synthesis, characterization, and biological evaluation of some novel \u03d2-aminobutyric acid aminotransferase (GABA-AT) inhibitors. Med Chem Res 31:1594\u20131610. https:\/\/doi.org\/10.1007\/s00044-022-02935-6","journal-title":"Med Chem Res"},{"issue":"1","key":"4244_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1684\/epd.2021.1255","volume":"23","author":"S Balestrini","year":"2021","unstructured":"Balestrini S, Arzimanoglou A, Bl\u00fcmcke I, Scheffer IE, Wiebe S, Zelano J, Walker MC (2021) The aetiologies of epilepsy. Epileptic Disord 23(1):1\u201316","journal-title":"Epileptic Disord"},{"issue":"4","key":"4244_CR139","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/1573406414666180116104225","volume":"14","author":"A Seth","year":"2018","unstructured":"Seth A, Sharma PA, Tripathi A, Choubey PK, Srivastava P, Tripathi PN, Shrivastava SK (2018) Design, synthesis, evaluation and computational studies of nipecotic acid-acetonaphthone hybrids as potential antiepileptic agents. Med Chem 14(4):409\u2013426. https:\/\/doi.org\/10.2174\/1573406414666180116104225","journal-title":"Med Chem"},{"issue":"1","key":"4244_CR140","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neurol.2015.11.003","volume":"172","author":"C Behr","year":"2016","unstructured":"Behr C, Goltzene MA, Kosmalski G, Hirsch E, Ryvlin P (2016) Epidemiology of epilepsy. Revue Neurologique 172(1):27\u201336","journal-title":"Revue Neurologique"},{"key":"4244_CR141","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.2147\/NDT.S107905","volume":"12","author":"S Liu","year":"2016","unstructured":"Liu S, Yu W, L\u00fc Y (2016) The causes of new-onset epilepsy and seizures in the elderly. Neuropsychiatr Dis Treat 12:1425\u20131434. https:\/\/doi.org\/10.2147\/NDT.S107905","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4244_CR142","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s00044-018-2141-9","volume":"27","author":"A Seth","year":"2018","unstructured":"Seth A, Sharma PA, Tripathi A, Choubey PK, Srivastava P, Tripathi PN, Shrivastava SK (2018) Design, synthesis, evaluation and molecular modeling studies of some novel N-substituted piperidine-3-carboxylic acid derivatives as potential anticonvulsants. Med Chem Res 27:1206\u20131225. https:\/\/doi.org\/10.1007\/s00044-018-2141-9","journal-title":"Med Chem Res"},{"issue":"3","key":"4244_CR143","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/1354750X.2020.1735521","volume":"25","author":"MI Hiskens","year":"2020","unstructured":"Hiskens MI, Schneiders AG, Angoa-P\u00e9rez M, Vella RK, Fenning AS (2020) Blood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy. Biomarkers 25(3):213\u2013227","journal-title":"Biomarkers"},{"issue":"10","key":"4244_CR144","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1111\/epi.17713","volume":"64","author":"S Akel","year":"2023","unstructured":"Akel S, Asztely F, Banote RK, Axelsson M, Zetterberg H, Zelano J (2023) Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: high plasma levels are rare but related to seizures. Epilepsia 64(10):2690\u20132700","journal-title":"Epilepsia"},{"key":"4244_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.647428","volume":"12","author":"RD Nass","year":"2021","unstructured":"Nass RD, Akg\u00fcn K, Dague KO, Elger CE, Reichmann H, Ziemssen T, Surges R (2021) CSF and serum biomarkers of cerebral damage in autoimmune epilepsy. Front Neurol 12:647428","journal-title":"Front Neurol"},{"key":"4244_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109131","volume":"140","author":"G Giovannini","year":"2023","unstructured":"Giovannini G, Bedin R, Orlandi N, Turchi G, Cioclu MC, Biagioli N et al (2023) Neuro-glial degeneration in status epilepticus: exploring the role of serum levels of neurofilament light chains and S100B as prognostic biomarkers for short-term functional outcome. Epilepsy Behav 140:109131","journal-title":"Epilepsy Behav"},{"key":"4244_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.579958","volume":"14","author":"KS Evers","year":"2020","unstructured":"Evers KS, H\u00fcgli M, Fouzas S, Kuhle J, Wellmann S (2020) Serum neurofilament levels in children with febrile seizures and in controls. Front Neurosci 14:579958","journal-title":"Front Neurosci"},{"issue":"1","key":"4244_CR148","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1111\/epi.17132","volume":"63","author":"G Giovannini","year":"2022","unstructured":"Giovannini G, Bedin R, Ferraro D, Vaudano AE, Mandrioli J, Meletti S (2022) Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus. Epilepsia 63(1):e23\u2013e29","journal-title":"Epilepsia"},{"issue":"2","key":"4244_CR149","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/epd2.20024","volume":"25","author":"M Ueda","year":"2023","unstructured":"Ueda M, Suzuki M, Hatanaka M, Nakamura T, Hirayama M, Katsuno M (2023) Serum neurofilament light chain in patients with epilepsy and cognitive impairment. Epileptic Disord 25(2):229\u2013236","journal-title":"Epileptic Disord"},{"issue":"7","key":"4244_CR150","doi-asserted-by":"publisher","first-page":"e2223821","DOI":"10.1001\/jamanetworkopen.2022.23821","volume":"5","author":"L Wang","year":"2022","unstructured":"Wang L, Zhang W, Liu F, Mao C, Liu CF, Cheng W, Feng J (2022) Association of cerebrospinal fluid neurofilament heavy protein levels with clinical progression in patients with Parkinson\u2019s disease. JAMA Netw Open 5(7):e2223821","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4244_CR151","doi-asserted-by":"publisher","first-page":"14114","DOI":"10.1038\/s41598-017-14179-1","volume":"7","author":"R Soylu-Kucharz","year":"2017","unstructured":"Soylu-Kucharz R, Sandelius \u00c5, Sj\u00f6gren M, Blennow K, Wild EJ, Zetterberg H, Bj\u00f6rkqvist M (2017) Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington\u2019s disease R6\/2 mice. Sci Rep 7(1):14114","journal-title":"Sci Rep"},{"issue":"8","key":"4244_CR152","doi-asserted-by":"publisher","first-page":"e717","DOI":"10.1212\/WNL.0000000000005005","volume":"90","author":"EB Johnson","year":"2018","unstructured":"Johnson EB, Byrne LM, Gregory S, Rodrigues FB, Blennow K, Durr A et al (2018) Neurofilament light protein in blood predicts regional atrophy in Huntington disease. Neurology 90(8):e717\u2013e723","journal-title":"Neurology"},{"issue":"23","key":"4244_CR153","doi-asserted-by":"publisher","first-page":"16632","DOI":"10.3390\/ijms242316632","volume":"24","author":"SH Loppi","year":"2023","unstructured":"Loppi SH, Tavera-Garcia MA, Scholpa NE, Maiyo BK, Becktel DA, Morrison HW et al (2023) Boosting mitochondrial biogenesis diminishes foam cell formation in the post-stroke brain. Int J Mol Sci 24(23):16632","journal-title":"Int J Mol Sci"},{"key":"4244_CR154","doi-asserted-by":"publisher","first-page":"1285359","DOI":"10.3389\/fnins.2023.1285359","volume":"17","author":"K Vlasakova","year":"2024","unstructured":"Vlasakova K, Tsuchiya T, Garfinkel IN, Ruth MP, Tyszkiewicz C, Detwiler TJ et al (2024) Performance of biomarkers NF-L, NSE, Tau and GFAP in blood and cerebrospinal fluid in rat for the detection of nervous system injury. Front Neurosci 17:1285359","journal-title":"Front Neurosci"},{"issue":"3","key":"4244_CR155","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/jnnp-2013-307454","volume":"86","author":"J Kuhle","year":"2015","unstructured":"Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A et al (2015) Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. J Neurol Neurosurg Psychiatry 86(3):273\u2013279","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"4244_CR156","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/acn3.51449","volume":"8","author":"E Nitz","year":"2021","unstructured":"Nitz E, Smitka M, Schallner J, Akg\u00fcn K, Ziemssen T, von der Hagen M, T\u00fcngler V (2021) Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children. Ann Clin Transl Neurol 8(10):2013\u20132024","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"4244_CR157","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/acn3.779","volume":"6","author":"BT Darras","year":"2019","unstructured":"Darras BT, Crawford TO, Finkel RS, Mercuri E, De Vivo DC, Oskoui M et al (2019) Neurofilament as a potential biomarker for spinal muscular atrophy. Ann Clin Transl Neurol 6(5):932\u2013944","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"4244_CR158","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/acn3.51336","volume":"8","author":"C Spicer","year":"2021","unstructured":"Spicer C, Lu CH, Catapano F, Scoto M, Zaharieva I, Malaspina A et al (2021) The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy. Ann Clin Transl Neurol 8(4):866\u2013876","journal-title":"Ann Clin Transl Neurol"},{"key":"4244_CR159","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16393","author":"G Musso","year":"2024","unstructured":"Musso G, Bello L, Capece G, Bozzoni V, Caumo L, Sabbatini D, Zangaro V, Sogus E, Cosma C, Petrosino A, Sorar\u00f9 G, Plebani M, Pegoraro E (2024) Neurofilament light chain and profilin-1 dynamics in 30 spinal muscular atrophy type 3 patients treated with nusinersen. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.16393","journal-title":"Eur J Neurol"},{"key":"4244_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2020.100056","volume":"3","author":"EM Gatto","year":"2020","unstructured":"Gatto EM, Rojas NG, Persi G, Etcheverry JL, Cesarini ME, Perandones C (2020) Huntington disease: advances in the understanding of its mechanisms. Clin Parkinsonism Relat Disord 3:100056","journal-title":"Clin Parkinsonism Relat Disord"},{"issue":"7","key":"4244_CR161","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024240","volume":"7","author":"M Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC (2017) Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med 7(7):a024240","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"4244_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147583","volume":"11","author":"DA Kuljis","year":"2016","unstructured":"Kuljis DA, Gad L, Loh DH, MacDowell Kaswan Z, Hitchcock ON, Ghiani CA, Colwell CS (2016) Sex differences in circadian dysfunction in the BACHD mouse model of Huntington\u2019s disease. PLoS ONE 11(2):e0147583","journal-title":"PLoS ONE"},{"issue":"458","key":"4244_CR163","doi-asserted-by":"publisher","first-page":"17108","DOI":"10.1126\/scitranslmed.aat7108","volume":"10","author":"LM Byrne","year":"2018","unstructured":"Byrne LM, Rodrigues FB, Johnson EB, Wijeratne PA, De Vita E, Alexander DC et al (2018) Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington\u2019s disease. Sci Transl Med 10(458):17108","journal-title":"Sci Transl Med"},{"key":"4244_CR164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0659-0","volume":"7","author":"A Forschner","year":"2019","unstructured":"Forschner A, Battke F, Hadaschik D, Schulze M, Wei\u00dfgraeber S, Han CT et al (2019) Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma\u2013results of a prospective biomarker study. J Immunother Cancer 7:1\u201315","journal-title":"J Immunother Cancer"},{"issue":"8","key":"4244_CR165","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","volume":"16","author":"LM Byrne","year":"2017","unstructured":"Byrne LM, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RA et al (2017) Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis. Lancet Neurol 16(8):601\u2013609","journal-title":"Lancet Neurol"},{"issue":"2","key":"4244_CR166","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10143-018-1008-3","volume":"43","author":"SA Quadri","year":"2020","unstructured":"Quadri SA, Farooqui M, Ikram A, Zafar A, Khan MA, Suriya SS, Claus CF, Fiani B, Rahman M, Ramachandran A, Armstrong IIT, Taqi MA, Mortazavi MM (2020) Recent update on basic mechanisms of spinal cord injury. Neurosurg Rev 43(2):425\u2013441. https:\/\/doi.org\/10.1007\/s10143-018-1008-3","journal-title":"Neurosurg Rev"},{"issue":"7","key":"4244_CR167","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/jpm12071130","volume":"12","author":"NM Vecin","year":"2022","unstructured":"Vecin NM, Gater DR (2022) Pressure injuries and management after spinal cord injury. J Pers Med 12(7):1130","journal-title":"J Pers Med"},{"issue":"6","key":"4244_CR168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006561","volume":"12","author":"MS Hossain","year":"2018","unstructured":"Hossain MS, Hasan MM, Islam MS, Islam S, Mozaffor M, Khan MAS et al (2018) Chikungunya outbreak (2017) in Bangladesh: clinical profile, economic impact and quality of life during the acute phase of the disease. PLoS Negl Trop Dis 12(6):e0006561","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"4244_CR169","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3390\/biomedicines11102617","volume":"11","author":"VM Saceleanu","year":"2023","unstructured":"Saceleanu VM, Toader C, Ples H, Covache-Busuioc RA, Costin HP, Bratu BG et al (2023) Integrative approaches in acute ischemic stroke: from symptom recognition to future innovations. Biomedicines 11(10):2617","journal-title":"Biomedicines"},{"key":"4244_CR170","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.clinbiomech.2018.03.019","volume":"64","author":"CF Jones","year":"2019","unstructured":"Jones CF, Clarke EC (2019) Engineering approaches to understanding mechanisms of spinal column injury leading to spinal cord injury. Clin Biomech 64:69\u201381","journal-title":"Clin Biomech"},{"issue":"1","key":"4244_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/neurosci3010001","volume":"3","author":"N Chopra","year":"2021","unstructured":"Chopra N, Menounos S, Choi JP, Hansbro PM, Diwan AD, Das A (2021) Blood-spinal cord barrier: its role in spinal disorders and emerging therapeutic strategies. NeuroSci 3(1):1\u201327","journal-title":"NeuroSci"},{"key":"4244_CR172","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fncel.2016.00098","volume":"10","author":"MA Anwar","year":"2016","unstructured":"Anwar MA, Al Shehabi TS, Eid AH (2016) Inflammogenesis of secondary spinal cord injury. Front Cell Neurosci 10:98","journal-title":"Front Cell Neurosci"},{"key":"4244_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-417044-5.00008-1","volume":"10","author":"A Alizadeh","year":"2019","unstructured":"Alizadeh A, Dyck SM, Karimi-Abdolrezaee S (2019) Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol 10:441408. https:\/\/doi.org\/10.1016\/B978-0-12-417044-5.00008-1","journal-title":"Front Neurol"},{"issue":"12","key":"4244_CR174","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1212\/WNL.0000000000206744","volume":"100","author":"S Stukas","year":"2023","unstructured":"Stukas S, Cooper J, Gill J, Fallah N, Skinnider MA, Belanger L et al (2023) Association of CSF and serum neurofilament light and glial fibrillary acidic protein, injury severity, and outcome in spinal cord Injury. Neurology 100(12):e1221\u2013e1233","journal-title":"Neurology"},{"issue":"1","key":"4244_CR175","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12883-023-03284-6","volume":"23","author":"I Hossain","year":"2023","unstructured":"Hossain I, Mohammadian M, Maanp\u00e4\u00e4 HR, Takala RS, Tenovuo O, van Gils M et al (2023) Plasma neurofilament light admission levels and development of axonal pathology in mild traumatic brain injury. BMC Neurol 23(1):304","journal-title":"BMC Neurol"},{"issue":"3","key":"4244_CR176","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/neu.2016.4435","volume":"34","author":"BK Kwon","year":"2017","unstructured":"Kwon BK, Streijger F, Fallah N, Noonan VK, B\u00e9langer LM, Ritchie L et al (2017) Cerebrospinal fluid biomarkers to stratify injury severity and predict outcome in human traumatic spinal cord injury. J Neurotrauma 34(3):567\u2013580","journal-title":"J Neurotrauma"},{"issue":"13\u201314","key":"4244_CR177","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1080\/02699052.2017.1351000","volume":"31","author":"JK Yue","year":"2017","unstructured":"Yue JK, Winkler EA, Sharma S, Vassar MJ, Ratcliff JJ, Korley FK et al (2017) Temporal profile of care following mild traumatic brain injury: predictors of hospital admission, follow-up referral and six-month outcome. Brain Inj 31(13\u201314):1820\u20131829","journal-title":"Brain Inj"},{"issue":"5","key":"4244_CR178","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458518765666","volume":"25","author":"N Siller","year":"2019","unstructured":"Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S et al (2019) Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis. Mult Scler J 25(5):678\u2013686","journal-title":"Mult Scler J"},{"issue":"4","key":"4244_CR179","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4103\/IJCIIS.IJCIIS_73_16","volume":"7","author":"A Singh","year":"2017","unstructured":"Singh A, Kumar V, Ali S, Mahdi AA, Srivastava RN (2017) Phosphorylated neurofilament heavy: a potential blood biomarker to evaluate the severity of acute spinal cord injuries in adults. Int J Crit Illn Inj Sci 7(4):212\u2013217","journal-title":"Int J Crit Illn Inj Sci"},{"key":"4244_CR180","doi-asserted-by":"publisher","unstructured":"Darras BT, Markowitz JA, Monani UR, Darryl C (2015) Spinal muscular atrophies. In: Neuromuscular disorders of infancy, childhood, and adolescence. pp 117\u2013145. https:\/\/doi.org\/10.1016\/B978-0-12-417044-5.00008-1","DOI":"10.1016\/B978-0-12-417044-5.00008-1"},{"issue":"5","key":"4244_CR181","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cpr.2013.03.006","volume":"33","author":"SM B\u00f6gels","year":"2013","unstructured":"B\u00f6gels SM, Knappe S, Clark LA (2013) Adult separation anxiety disorder in DSM-5. Clin Psychol Rev 33(5):663\u2013674","journal-title":"Clin Psychol Rev"},{"issue":"2","key":"4244_CR182","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ana.26860","volume":"95","author":"M Benatar","year":"2024","unstructured":"Benatar M, Ostrow LW, Lewcock JW, Bennett F, Shefner J, Bowser R et al (2024) Biomarker qualification for neurofilament light chain in amyotrophic lateral sclerosis: theory and practice. Ann Neurol 95(2):211\u2013216","journal-title":"Ann Neurol"},{"issue":"3","key":"4244_CR183","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrm3753","volume":"15","author":"NT Snider","year":"2014","unstructured":"Snider NT, Omary MB (2014) Post-translational modifications of intermediate filament proteins: mechanisms and functions. Nat Rev Mol Cell Biol 15(3):163\u2013177","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"4244_CR184","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.braindev.2023.07.005","volume":"45","author":"G Seo","year":"2023","unstructured":"Seo G, Kim S, Byun JC, Kwon S, Lee YJ (2023) Evaluation of the neurofilament light chain as a biomarker in children with spinal muscular atrophy treated with nusinersen. Brain Dev 45(10):554\u2013563","journal-title":"Brain Dev"},{"issue":"1","key":"4244_CR185","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40364-023-00448-x","volume":"11","author":"K Campbell","year":"2023","unstructured":"Campbell K, Cawley NX, Luke R, Scott KE, Johnson N, Farhat NY et al (2023) Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1. Biomark Res 11(1):14","journal-title":"Biomark Res"},{"key":"4244_CR186","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.689938","volume":"15","author":"A Yuan","year":"2021","unstructured":"Yuan A, Nixon RA (2021) Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies. Front Neurosci 15:689938","journal-title":"Front Neurosci"},{"issue":"2","key":"4244_CR187","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1176\/appi.neuropsych.20090238","volume":"33","author":"PS Pressman","year":"2021","unstructured":"Pressman PS, Matlock D, Ducharme S (2021) Distinguishing behavioral variant frontotemporal dementia from primary psychiatric disorders: a review of recently published consensus recommendations from the Neuropsychiatric International Consortium for Frontotemporal Dementia. J Neuropsychiatry Clin Neurosci 33(2):152\u2013156","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"4244_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.959261","volume":"16","author":"Y Liu","year":"2022","unstructured":"Liu Y, Dou K, Xue L, Li X, Xie A (2022) Neurofilament light as a biomarker for motor decline in Parkinson\u2019s disease. Front Neurosci 16:959261","journal-title":"Front Neurosci"},{"issue":"11","key":"4244_CR189","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018242","volume":"8","author":"H Herrmann","year":"2016","unstructured":"Herrmann H, Aebi U (2016) Intermediate filaments: structure and assembly. Cold Spring Harb Perspect Biol 8(11):a018242","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4244_CR190","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s43440-020-00107-0","volume":"72","author":"P Lewczuk","year":"2020","unstructured":"Lewczuk P, \u0141ukaszewicz-Zaj\u0105c M, Mroczko P, Kornhuber J (2020) Clinical significance of fluid biomarkers in Alzheimer\u2019s disease. Pharmacol Rep 72:528\u2013542","journal-title":"Pharmacol Rep"},{"issue":"1","key":"4244_CR191","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/acn3.143","volume":"2","author":"OM Peters","year":"2015","unstructured":"Peters OM, Shelkovnikova T, Highley JR, Cooper-Knock J, Hortob\u00e1gyi T, Troakes C et al (2015) Gamma-synuclein pathology in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 2(1):29\u201337","journal-title":"Ann Clin Transl Neurol"},{"key":"4244_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.712245","volume":"12","author":"YN Zhou","year":"2021","unstructured":"Zhou YN, Chen YH, Dong SQ, Yang WB, Qian T, Liu XN et al (2021) Role of blood neurofilaments in the prognosis of amyotrophic lateral sclerosis: a meta-analysis. Front Neurol 12:712245","journal-title":"Front Neurol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04244-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04244-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04244-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T05:07:53Z","timestamp":1729746473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04244-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":192,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["4244"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04244-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) report no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}